Bioscience Animal Health PCL
SET:BIS
Bioscience Animal Health PCL
Note Receivable
Bioscience Animal Health PCL
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
Note Receivable
฿26.6m
|
CAGR 3-Years
66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Winnergy Medical PCL
SET:WINMED
|
Note Receivable
฿10.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Business Alignment PCL
SET:BIZ
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Techno Medical PCL
SET:TM
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
E for L Aim PCL
SET:EFORL
|
Note Receivable
฿7.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
101%
|
CAGR 10-Years
-5%
|
|
|
S
|
SEI Medical PCL
SET:SEI
|
Note Receivable
฿9.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bioscience Animal Health PCL
Glance View
Bioscience Animal Health Public Co. Ltd. engages in manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company is headquartered in Pak Kret, Nonthaburi. The company went IPO on 2022-05-05. The firm is an importer and distributor of medical supplies, tools, equipment and products for livestock and pets. The company focuses on selecting products by specialist veterinarians to improve animal health. The firm's products include antibiotic, additive, BiSMiX B-Series, BiSMiX SD Series, injection, mold inhibitor, water-soluble products, vaccine and certificate bioscience. The antibiotic includes Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Its additive pHorce, orego-stim-powder, Optiphos, Moldgard, Mastercube and Lianol solapro. The injection consists of Zuprevo, Nuflor, Ceva and Enzaprost. The water-soluble products consist of Tilmosin AC, Surmox col and Coliscour. The firm's subsidiaries include Feed and Ingredients Technological Hub Co., Ltd., Special Ingredient Services Co., Ltd., and others.
See Also
What is Bioscience Animal Health PCL's Note Receivable?
Note Receivable
26.6m
THB
Based on the financial report for Dec 31, 2024, Bioscience Animal Health PCL's Note Receivable amounts to 26.6m THB.
What is Bioscience Animal Health PCL's Note Receivable growth rate?
Note Receivable CAGR 3Y
66%
Over the last year, the Note Receivable growth was 249%. The average annual Note Receivable growth rates for Bioscience Animal Health PCL have been 66% over the past three years .
